Informações:
Falhas:
ID
13201
Descrição
Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOP; ODM derived from: https://clinicaltrials.gov/show/NCT01868035
Link
https://clinicaltrials.gov/show/NCT01868035
Palavras-chave
Versões (1)
- 23/01/2016 23/01/2016 -
Transferido a
23 de janeiro de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Lymphoma, Non-Hodgkin NCT01868035
Eligibility Lymphoma, Non-Hodgkin NCT01868035
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoma, Non-Hodgkin NCT01868035
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
gender, age, chemotherapy
Item
male or female subjects age 18 to 80 years, inclusive, with any international prognostic index score; treated with 6 or more cycles of first-line chop chemotherapy and achieved a pr, cru, or cr
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
C1704632 (UMLS CUI [4])
C0001779 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
C1704632 (UMLS CUI [4])
diffuse large b-cell nhl
Item
de novo diffuse large b-cell nhl according to the real classification; ann arbor stage iii, stage iv, or bulky stage ii disease (any mass ≥10 cm in diameter)
boolean
C0079744 (UMLS CUI [1])
bone marrow biopsy, cd20
Item
less than an average of 25% of the intratrabecular marrow space involved by nhl in bilateral bone marrow biopsy specimens or <10% involvement with nhl from unilateral bone marrow biopsy; tumor tissue expressing the cd20 antigen
boolean
C0005954 (UMLS CUI [1])
C0054946 (UMLS CUI [2])
C0054946 (UMLS CUI [2])
karnofsky, life expectancy
Item
≥60% performance status on the karnofsky performance scale and an anticipated survival of at least 3 months
boolean
C0206065 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
C0023671 (UMLS CUI [2])
anc, platelet count
Item
absolute neutrophil count (anc) ≥1500 cells/mm3 and platelet count ≥100,000/mm3
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0032181 (UMLS CUI [2])
creatinine, bilirubin, ast
Item
adequate renal function (serum creatinine <1.5 × upper limit of normal [uln]) and hepatic function (total bilirubin ≤2.0 × uln and aspartate aminotransferase <5 × uln)
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
therapy
Item
prior radiation, prior biological therapy, or prior chemotherapy other than first-line chop
boolean
C0087111 (UMLS CUI [1])
hydronephrosis
Item
active bilateral obstructive hydronephrosis
boolean
C0521622 (UMLS CUI [1])
nyha
Item
new york heart association class iii or iv heart disease or other serious illness
boolean
C1275491 (UMLS CUI [1])
malignancy
Item
prior malignancy other than lymphoma (except for adequately treated skin cancer, in situ cervical cancer, or other cancer for which they had been disease-free for >5 years)
boolean
C0006826 (UMLS CUI [1])
hiv
Item
human immunodeficiency virus infection
boolean
C0019682 (UMLS CUI [1])
hama
Item
hama positive
boolean
C1291910 (UMLS CUI [1])
cns metastases
Item
brain or leptomeningeal metastases at any time since diagnosis
boolean
C0686377 (UMLS CUI [1])
infection
Item
active infection requiring intravenous anti-infectives
boolean
C0009450 (UMLS CUI [1])
pregnancy, lactation
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])